Literature DB >> 29587895

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders.

Tatiana Oviedo-Salcedo1, Lot de Witte2, Tania Kümpfel3, René S Kahn2, Peter Falkai4, Peter Eichhorn5, Jurjen Luykx6, Alkomiet Hasan4.   

Abstract

Antibody-mediated encephalitis has been discussed as one possible cause for isolated psychotic syndromes. Mostly based on serum samples, findings have been controversial. We present the results of a retrospective study of 124 clinically diagnosed psychotic patients without documented relevant neurological symptoms. All were tested for different antineuronal antibodies in cerebrospinal fluid (CSF) while 81 received serum testing. Antineuronal antibodies in CSF were negative across the sample. 3.7% showed low positive serum antibodies. Our findings highlight the importance of a deeper discussion about the relevance of low positive serum antibodies without concurrent findings in CSF or clinical signs for autoimmune encephalitis.Declaration of interestNone.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29587895     DOI: 10.1192/bjp.2018.24

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  11 in total

Review 1.  Neuroinflammation and Schizophrenia.

Authors:  Peter F Buckley
Journal:  Curr Psychiatry Rep       Date:  2019-07-03       Impact factor: 5.285

2.  The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.

Authors:  Adam Al-Diwani; Adam Handel; Leigh Townsend; Thomas Pollak; M Isabel Leite; Paul J Harrison; Belinda R Lennox; David Okai; Sanjay G Manohar; Sarosh R Irani
Journal:  Lancet Psychiatry       Date:  2019-02-11       Impact factor: 27.083

Review 3.  Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.

Authors:  Dominique Endres; Frank Leypoldt; Karl Bechter; Alkomiet Hasan; Johann Steiner; Katharina Domschke; Klaus-Peter Wandinger; Peter Falkai; Volker Arolt; Oliver Stich; Sebastian Rauer; Harald Prüss; Ludger Tebartz van Elst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-12       Impact factor: 5.270

4.  Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach.

Authors:  Niels Hansen; Michael Lipp; Jonathan Vogelgsang; Ruth Vukovich; Tristan Zindler; Daniel Luedecke; Stefan Gingele; Berend Malchow; Helge Frieling; Simone Kühn; Johannes Denk; Jürgen Gallinat; Thomas Skripuletz; Nicole Moschny; Jens Fiehler; Christian Riedel; Klaus Wiedemann; Mike P Wattjes; Inga Zerr; Hermann Esselmann; Stefan Bleich; Jens Wiltfang; Alexandra Neyazi
Journal:  Brain Behav Immun Health       Date:  2020-10-01

5.  Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis.

Authors:  Fredrik Piehl; Sarosh R Irani; Jakob Theorell; Melanie Ramberger; Ruby Harrison; Victor Mgbachi; Leslie Jacobson; Patrick Waters; Sophie Erhardt; Carl M Sellgren; Simon Cervenka
Journal:  Transl Psychiatry       Date:  2021-11-05       Impact factor: 6.222

6.  Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables.

Authors:  Tatiana Oviedo-Salcedo; Elias Wagner; Mattia Campana; Anna Gagsteiger; Wolfgang Strube; Peter Eichhorn; Marie-Luise Louiset; Jurjen Luykx; Lot D de Witte; René S Kahn; Michael E Benros; Peter Falkai; Alkomiet Hasan
Journal:  Transl Psychiatry       Date:  2021-12-08       Impact factor: 6.222

7.  Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis.

Authors:  Thomas A Pollak; Belinda R Lennox
Journal:  BJPsych Open       Date:  2018-07-16

8.  A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders.

Authors:  M B Schou; S G Sæther; O K Drange; E Brenner; J Crespi; L Eikenes; M S Mykland; C Pintzka; A K Håberg; T Sand; A Vaaler; D Kondziella
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

9.  Diagnosing Organic Causes of Schizophrenia Spectrum Disorders: Findings from a One-Year Cohort of the Freiburg Diagnostic Protocol in Psychosis (FDPP).

Authors:  Dominique Endres; Miriam Matysik; Bernd Feige; Nils Venhoff; Tina Schweizer; Maike Michel; Sophie Meixensberger; Kimon Runge; Simon J Maier; Kathrin Nickel; Karl Bechter; Horst Urbach; Katharina Domschke; Ludger Tebartz van Elst
Journal:  Diagnostics (Basel)       Date:  2020-09-14

10.  Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany.

Authors:  Frank Leypoldt; Ludger Tebartz van Elst; Dominique Endres; Eva Lüngen; Alkomiet Hasan; Michael Kluge; Sabrina Fröhlich; Jan Lewerenz; Tom Bschor; Ida Sibylle Haußleiter; Georg Juckel; Florian Then Bergh; Barbara Ettrich; Lisa Kertzscher; Tatiana Oviedo-Salcedo; Robert Handreka; Martin Lauer; Klaas Winter; Norbert Zumdick; Anna Drews; Jost Obrocki; Yavor Yalachkov; Anna Bubl; Felix von Podewils; Udo Schneider; Kristina Szabo; Margarete Mattern; Alexandra Philipsen; Katharina Domschke; Klaus-Peter Wandinger; Alexandra Neyazi; Oliver Stich; Harald Prüss
Journal:  Mol Psychiatry       Date:  2022-01-19       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.